Abstract:Translational medicine is known as biomedicine models with purpose of finding solutions for clinical challenges. The clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system makes impressive strides therein through gene knockout, knock‐in, activation, interference, base editing, and sequence detection, and continues to revolutionize the development of translational medicine. Translational medicine aims to improve human health by exploring potential treatment methods developed during basic scientific research and applying them to the treatment of patients in clinical settings. The advanced perceptions of gene functions have remarkably revolutionized clinical treatment strategies for target agents. However, the progress in gene editing therapy has been hindered due to the severe off‐target effects and limited editing sites. Fortunately, the development in the clustered regularly interspaced short palindromic repeats associated protein 9 (CRISPR‐Cas9) system has renewed hope for gene therapy field. The CRISPR‐Cas9 system can fulfill various simple or complex purposes, including gene knockout, knock‐in, activation, interference, base editing, and sequence detection. Accordingly, the CRISPR‐Cas9 system is adaptable to translational medicine, which calls for the alteration of genomic sequences. This review aims to present the latest CRISPR‐Cas9 technology achievements and prospect to translational medicine advances. The principle and characterization of the CRISPR‐Cas9 system are firstly introduced. The authors then focus on recent pre‐clinical and clinical research directions, including the construction of disease models, disease‐related gene screening and regulation, and disease treatment and diagnosis for multiple refractory diseases. Finally, some clinical challenges including off‐target effects, in vivo vectors, and ethical problems, and future perspective are also discussed.

Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems

SgRNA Engineering for Improved Genome Editing and Expanded Functional Assays.

Controlling CRISPR-Cas9 by guide RNA engineering

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Development and application of CRISPR/Cas9 technologies in genomic editing.

Spatiotemporal control of CRISPR/Cas9 gene editing

Reducing CRISPR-Cas9 off-target effects by optically controlled chemical modifications of guide RNA

Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing

Efficient expression of multiple guide RNAs for CRISPR/Cas genome editing

Recent Progress in CRISPR/Cas9 Technology

CRISPR/Cas9 in Genome Editing and Beyond

Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System

Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing

Modulating CRISPR/Cas9 genome-editing activity by small molecules

A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs**

Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity

Research Progress of CRISPR-Cas9 Functional Regulation System Based on Small Molecule Reaction Tools

Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications